Sudanese Medicinal Plants and Their Endophytic Fungi as Sources of Antifungal Agents.
5 affiliations
- 1Research Centre for Plant Growth and Development, School of Agriculture and Science, University of KwaZulu-Natal Pietermaritzburg, Private Bag X01, Scottsville 3209, South Africa.
- 2Department of Horticulture, Faculty of Agriculture, University of Khartoum, Shambat, Khartoum 13314, Sudan.
- 3Department of Botany, Faculty of Science, University of Khartoum, P.O. Box 321, Khartoum 13314, Sudan.
- 4Department of Chemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor 16680, Indonesia.
- 5Tropical Biopharmaca Research Center, IPB University, Bogor 16128, Indonesia.
Abstract
In Sudan, the widespread occurrence of fungal diseases, along with limited access to modern medicine, highlights the therapeutic significance of indigenous medicinal plants. Globally, both medicinal plants and their associated endophytic fungi constitute a major natural reservoir for novel antifungal compounds. This paper reviews the antifungal research undertaken on Sudanese medicinal plants and their endophytic fungi during the period 2000-2025. The literature survey was conducted using the databases Google Scholar, ScienceDirect, PubMed, Scopus, and Web of Science. In this review, a total of 88 plant species belonging to 51 families were investigated for antifungal activity, predominantly against species of Candida, Saccharomyces and Aspergillus. Among these, 16 species were specifically tested against Madurella mycetomatis, the primary causative agent of eumycetoma. The family Fabaceae was the most screened family. Analysis of the publications reviewed indicated that the majority of papers used the cup-plate diffusion method for assaying antifungal activity. The minimum inhibitory concentration was the most prominent assay used to detect anti-M. mycetomatis. Plant extracts of the Combretaceae family, Boswellia papyrifera and Pimpinella anisum essential oil, displayed promising antifungal activity. In addition, Alternaria sp., Curvularia sp. and Pleospora sp. endophytic fungi isolated from Vachellia nilotica and Cymbopogon schoenanthus also showed promising antifungal activity. Further investigation into fungal endophytes is essential to characterize species diversity and identify novel bioactive metabolites. Implementing a modernized research framework for Sudanese medicinal plants is critical for developing novel antifungal leads.
Related
- Integrated counter current separation and omics approaches for discovery of bioactive compounds from medicinal plants
- Comparative Ethnopharmacological Insights Into Anti-Inflammatory Phytochemicals From Indian and Chinese Medicinal Plants in the Management of Rheumatoid Arthritis
- Comparative Enzyme Inhibitory and Antioxidant Activities of Selected Turkish Medicinal Plants With LC-MS/MS Profiling of Morus nigra Extract.
- Medicinal plants of the Ukraine: from Prince Volodymyr (10th century) to medicinal Cannabis (2026)
- A quantitative screening strategy based on activity-content ratio for prioritizing bioactive compounds in medicinal plants
BibTeX
@article{muddathir2026sudanese,
title = {{Sudanese Medicinal Plants and Their Endophytic Fungi as Sources of Antifungal Agents.}},
author = {Ali Mahmoud Muddathir and Sakina Yagi and Irmanida Batubara and Johannes Van Staden},
journal = {Plants (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/plants15203163},
url = {https://europepmc.org/article/MED/42943116},
note = {CC BY},
}
RIS
TY - JOUR
TI - Sudanese Medicinal Plants and Their Endophytic Fungi as Sources of Antifungal Agents.
AU - Ali Mahmoud Muddathir
AU - Sakina Yagi
AU - Irmanida Batubara
AU - Johannes Van Staden
PY - 2026
DA - 2026/10/15
JO - Plants (Basel, Switzerland)
DO - 10.3390/plants15203163
UR - https://europepmc.org/article/MED/42943116
AB - In Sudan, the widespread occurrence of fungal diseases, along with limited access to modern medicine, highlights the therapeutic significance of indigenous medicinal plants. Globally, both medicinal plants and their associated endophytic fungi constitute a major natural reservoir for novel antifungal compounds. This paper reviews the antifungal research undertaken on Sudanese medicinal plants and their endophytic fungi during the period 2000-2025. The literature survey was conducted using the databases Google Scholar, ScienceDirect, PubMed, Scopus, and Web of Science. In this review, a total of 88 plant species belonging to 51 families were investigated for antifungal activity, predominantly against species of Candida, Saccharomyces and Aspergillus. Among these, 16 species were specifically tested against Madurella mycetomatis, the primary causative agent of eumycetoma. The family Fabaceae was the most screened family. Analysis of the publications reviewed indicated that the majority of papers used the cup-plate diffusion method for assaying antifungal activity. The minimum inhibitory concentration was the most prominent assay used to detect anti-M. mycetomatis. Plant extracts of the Combretaceae family, Boswellia papyrifera and Pimpinella anisum essential oil, displayed promising antifungal activity. In addition, Alternaria sp., Curvularia sp. and Pleospora sp. endophytic fungi isolated from Vachellia nilotica and Cymbopogon schoenanthus also showed promising antifungal activity. Further investigation into fungal endophytes is essential to characterize species diversity and identify novel bioactive metabolites. Implementing a modernized research framework for Sudanese medicinal plants is critical for developing novel antifungal leads.
SN - 2223-7747
ER -